Abstract:BACKGROUND: Cardiac CD206+ macrophages expand acutely after myocardial infarction (MI) to promote wound healing; however, their role in chronic heart failure (HF) is unknown. We tested the hypothesis that cardiac CD206+ macrophages expressing interleukin(IL)-4Ralpha are key drivers of adverse left ventricular (LV) remodeling in HF. METHODS AND RESULTS: Adult male C57BL/6 mice underwent non-reperfused MI to induce HF, or sham operation, and cardiac macrophages were profiled using flow cytometry. As compared to sham, CD206+ macrophages steadily expanded in post-MI hearts during LV remodeling, such that at 8 w post-MI they comprised ~85% of all macrophages. These macrophages were robustly proliferative and predominantly C-C motif chemokine receptor (CCR2)− and major histocompatibility complex (MHC)IIhi, with >90% of CD206+CCR2− macrophages expressing the resident macrophage marker LYVE-1. CD206+ macrophage abundance correlated with LV dysfunction and fibrosis. Nearly half of CD206+ macrophages expressed IL-4Ralpha, and the majority of CD206+IL-4Ralpha+ macrophages co-expressed the pro-fibrotic protein found in inflammatory zone (FIZZ)1. IL-4-polarized bone marrow derived CD206+ macrophages also exhibited marked upregulation of FIZZ1 and induced FIZZ1-dependent myofibroblast differentiation of cardiac mesenchymal stem cells (cMSCs), in part related to DLL-4/Jagged1-Notch1 signaling. Intramyocardial adoptive transfer of M[IL-4], but not M[IL-10], CD206+ macrophages to naive mice, induced progressive LV remodeling over 4 weeks, increasing fibrosis, cardiomyocyte hypertrophy, and apoptosis. Myeloid-specific IL-4Ralpha gene deletion in established HF (initiated 4 w post-MI) in IL-4Ralphaf/fLysM-CreERT2 mice significantly reduced CD206+ macrophage proliferation and effectively depleted CD206+IL-4Ralpha+ cardiac macrophages. This was associated with abrogation of LV remodeling progression, reduction of cardiac fibrosis, and improved neovascularization. In vivo IL-4Ralpha gene silencing in mice with established HF effectively depleted cardiac CD206+IL-4Ralpha+ macrophages and reversed LV remodeling, improving fibrosis, neovascularization, and dysfunction, and suppressed both local and systemic inflammation. Lastly, alternatively activated CD206+ and CD163+ macrophages were significantly expanded in human failing hearts and correlated with fibrosis. The majority of CD163+ macrophages expressed IL-4Ralpha and FIZZ3, the human homolog of FIZZ1. CONCLUSION: Cardiac CD206+IL-4Ralpha+ macrophages proliferate and expand in HF and are key mediators of pathological remodeling and fibrosis, in part through the secretion of FIZZ1. Inhibition of CD206+ macrophage IL-4Ralpha signaling alleviates LV remodeling in ischemic cardiomyopathy.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **Are cardiac CD206+IL - 4Rα+ macrophages the key drivers of left ventricular adverse remodeling in heart failure caused by ischemic cardiomyopathy?** ### Background and Problem Statement Heart failure (HF) is a complex pathological state, accompanied by local and systemic inflammatory responses. In ischemic cardiomyopathy, activated macrophages expand in the damaged myocardium and promote tissue damage and left ventricular (LV) adverse remodeling. Although it is known that CD206+ macrophages expand to promote wound healing after acute myocardial infarction (MI), their role in chronic heart failure remains unclear. ### Research Hypothesis The researchers hypothesized that in chronic heart failure, cardiac CD206+ macrophages express interleukin - 4 receptor α (IL - 4Rα), and these macrophages are the key drivers of left ventricular adverse remodeling. Specifically, the researchers speculated that these macrophages mediate cardiac remodeling and fibrosis by secreting pro - fibrotic proteins such as FIZZ1. ### Method and Result Overview To test this hypothesis, the researchers conducted the following experiments: 1. **Mouse Model**: - Adult male C57BL/6 mice underwent non - reperfused MI surgery to induce heart failure or received sham surgery. - Flow cytometry was used to analyze the characteristics of cardiac macrophages. It was found that at 8 weeks after MI, CD206+ macrophages accounted for approximately 85% of all macrophages and were associated with LV dysfunction and fibrosis. 2. **Macrophage Phenotype Analysis**: - CD206+ macrophages were mainly CCR2 - negative and highly expressed MHCII, and more than 90% of CD206+CCR2 - macrophages expressed the resident macrophage marker LYVE - 1. - Nearly half of the CD206+ macrophages expressed IL - 4Rα, and most CD206+IL - 4Rα+ macrophages co - expressed the pro - fibrotic protein FIZZ1. 3. **Mechanism Study**: - IL - 4 - polarized bone marrow - derived CD206+ macrophages significantly up - regulated FIZZ1 expression and induced cMSCs to differentiate into myofibroblasts, partly depending on the DLL4/Jagged1 - Notch1 signaling pathway. - Injection of M[IL - 4] CD206+ macrophages into the naive mouse heart could induce progressive LV remodeling, increase fibrosis, cardiomyocyte hypertrophy and apoptosis. 4. **Gene Knock - out Experiment**: - Specific deletion of the IL - 4Rα gene in myeloid cells in IL - 4Rαf/fLysM - CreERT2 mice significantly reduced the proliferation of CD206+ macrophages and effectively depleted CD206+IL - 4Rα+ cardiac macrophages. - This intervention alleviated the progress of LV remodeling, reduced cardiac fibrosis and improved neovascularization. 5. **In Vivo Gene Silencing Experiment**: - In vivo silencing of the IL - 4Rα gene by ASO technology effectively depleted CD206+IL - 4Rα+ macrophages in the heart, reversed LV remodeling, improved fibrosis, neovascularization and dysfunction, and inhibited local and systemic inflammation. 6. **Human Sample Analysis**: - In human heart failure hearts, alternatively activated CD206+ and CD163+ macrophages expanded significantly and were associated with fibrosis. - Most CD163+ macrophages expressed IL - 4Rα and FIZZ3 (the human homolog of FIZZ1). ### Conclusion Cardiac CD206+IL - 4Rα+ macrophages proliferate and expand in heart failure and are important mediators of pathological remodeling and fibrosis, partly through secreting FIZZ1. Inhibiting IL - 4Rα signaling in CD206+ macrophages can relieve LV remodeling in ischemic cardiomyopathy. Therefore, targeting IL - 4 signaling may be a potential therapeutic strategy to limit long - term cardiac remodeling in heart failure. ### Keywords CD206+ macrophages; Fibrosis; Heart failure; Interleukin - 4 receptor α; Inflammation

CD206+IL-4Ralpha+ MACROPHAGES ARE DRIVERS OF ADVERSE CARDIAC REMODELING IN ISCHEMIC CARDIOMYOPATHY

Emerging Roles of Macrophages in Heart Failure and Associated Treatment Approaches

CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction

Macrophage-Expressed Coagulation Factor 7 Promotes Adverse Cardiac Remodeling

Cross-talk Between Macrophages and Atrial Myocytes in Atrial Fibrillation

Macrophage-Specific NLRC5 Protects From Cardiac Remodeling Through Interaction With HSPA8

Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction

Resident and recruited macrophages differentially contribute to cardiac healing after myocardial ischemia

IL-27 promotes cardiac fibroblast activation and aggravates cardiac remodeling post myocardial infarction

CCL24/CCR3 Axis Plays a Central Role in Angiotensin II–induced Heart Failure by Stimulating M2 Macrophage Polarization and Fibroblast Activation

Cardiac Resident Macrophages Prevent Fibrosis and Stimulate Angiogenesis

Macrophage-derived CCL24 promotes fibrosis and worsens cardiac dysfunction during heart failure

Insight into the Pro-inflammatory and Profibrotic Role of Macrophage in Heart Failure with Preserved Ejection Fraction.

Cardiac sympathetic overdrive, M2 macrophage activation and fibroblast heterogeneity are associated with cardiac remodeling in a chronic pressure overload rat model of HFpEF

Different Roles of Resident and Non-resident Macrophages in Cardiac Fibrosis

Macrophage MKL1 contributes to cardiac fibrosis in a mouse model of myocardial infarction

Cardiac macrophages in maintaining heart homeostasis and regulating ventricular remodeling of heart diseases

Cardiac resident macrophages: key regulatory mediators in the aftermath of myocardial infarction

Interleukin-34-NF-κB signaling aggravates myocardial ischemic/reperfusion injury by facilitating macrophage recruitment and polarization

Transcriptional regulation of macrophage inflammation in the heart failure with preserved ejection fraction